Epocrates Inc., the US firm specialising in mobile systems for the healthcare industry, has announced its expansion into the global market today with the introduction of local brand and generic drug names integrated into its clinical applications.
The company's mobile applications, including the Epocrates Rx free drug reference and its Epocrates Essentials premium drug, disease and diagnostic guide, now incorporate drug name indexes for four countries - Canada, Germany, Spain and the United Kingdom.
Eprocrates says the addition of the local drug indexes will be followed by the addition of enhanced clinical content and additional services, including news alerts, medical education and market research. The company also plans to expand into additional countries, including France and Italy, in 2006.
![[RSS 0.92 feed]](http://medicalpda.net/img/xml.gif)
